Muhammad T Al-Lozi, MD

Professor of Neurology

Phone314-362-6981

Fax314-362-3752

Emailallozim@neuro.wustl.edu

Additional Titles

  • Section Co-Chief, Clinical Neurophysiology
  • Director, Neuromuscular Medicine Program

Board Certifications

  • Clinical Neurophysiology
  • Electrodiagnostic Medicine
  • Neurology
  • Neuromuscular Medicine

Related Links

Recognition

  • Washington University Distinguished Faculty Award, 2016.
  • The Sven Eliasson Award for Teaching Excellence: Washington University in Saint Louis, department of Neurology (2009-2010)
  • The Sven Eliasson Award for Teaching Excellence: Washington University in Saint Louis, department of Neurology (2007-2008)
  • Listed in Best Doctors in America: since 2007 till present.
  • A.B. Baker Teaching recognition award: American Academy of Neurology (AAN): 2007
  • The Sven Eliasson Award for Teaching excellence: Washington University in Saint Louis, department of Neurology (2005-2006)
  • Listed in America’s top Physicians since 2005
  • The Sven Eliasson Award for Teaching excellence: Washington University in Saint Louis, department of Neurology (2004-2005)
  • Clinical Teacher of the Year award: Washington University School of Medicine-Saint Louis (2003)
  • The Sven Eliasson Award for Teaching excellence: Washington University in Saint Louis, department of Neurology (1995-1996)
  • Tom Preziosi Award for Clinical Excellence: Johns Hopkins Hospitals-Neurology Residency Program (1991)

Publications

  • Bhatt NK, Park AM, Al-Lozi M, Paneillo RC. Compound Motor Action Potential Quantifies recurrent laryngeal nerve innervation in a canine model. Ann Otol Rhinol Laryngol. 2016;125(7):584-90
  • Paniello RC, Park AM, Bhatt NK, Al-Lozi M. Recurrent laryngeal recovery patterns assessed by serial electromyography. Lyarngoscope. 2016; 126:651-6
  • Kallianpur AR et al (CHARTER Group). Anemia and red cell indices predict HIV-Associated neurocognitive imp;airement in the HAART era. J Infect Dis. 2016;213:1065-73
  • Hulgan T et al (CHARTER Group). Mitochondrial DNA haplogroups and neurocognitive impairment during HIV infection. Clin Infect Dis. 2015;61:1476-84
  • Ong, CJ, Al-Lozi M, Cimino PJ, Bucell, R. Peripheral nervous system hyperexcitability in VV2 sporadic CJD. Neurology practice. 2015;5:326-332
  • Anderson Am (CHARTER Group). CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015;21:559-67
  • McGuire JL et al. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J Neurovirol. 2015;21:439-48
  • Malvar J et al. Predictors of new-onset distal neruoapthic pain in HIV-infected individuals in the ear of combination antiretroviral therapy. Pain. 2015;156:731-9
  • Clifford et al. Absence of neurocognitive effect of hepatitis C infection in HIV-co-infected people. Neurology 2015; 84: 241-50
  • Scoto et al. Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology 2015:84:668-79
  • Archibald SL et al. Brain morphometric correlates of metabolic variables in HIV: the CHARTER study. J Neurovirol. 2014; 20: 603-11
  • Dale AM, Agboola F, Yun A, Zernigue A, Al-Lozi MT, Evanoff B. Comparison of automated versus traditional nerve conduction study methods for median nerve testing in general worker population. PMR 2014; 14: S1934-1482
  • Kallianpur AR et al (CHARTER Group). Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV infected patients with antiretroviral therapy. PLoS one. 2014;9:e103123
  • Fennema-Notentine et al (CHARTER Group). Increases in brain white matter abnormalities and subcortical gray matter are linkged to CD4 recovery in HIV infection. J Neurovirol 2013;19:292-401
  • Manousakis G, Koch J, Sommerville RB, El-Kokla A, Harms MB, Al-Lozi MT, Schmidt RE, Pestronk A. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve. 2013;48:440-4
  • Morgan EE et al (CHARTER Group). Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J neurovirol. 2013;19:150-6
  • Nguyen et al (CHARTER Group). Etravirine in CSF is highly protein bound. J antimicrob Chemother. 2013;68:1161-8
  • Croteau D et al (CHARTER group). Darunavir is predominantly unbound to protein in cerebrospinal fluid and concentrations exceed the wild-type HIV-1 median 90% inhibitory concentration. J Antimicrob Chemother. 2013;68:684-9
  • Sakamoto M et al (CHARTER Group). Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER cohort. J Acquir Immune Defic Syndr. 2013;62:36-42
  • Hozinger ER etal (CHARTER Group). Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol. 2012;18:511-20
  • Pestronk A, Schmidt RE, Choski RM, Sommerville RB, Al-Lozi MT. Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS. Muscle Nerve. 2012;45:866-72
  • Choi JY (CHARTER group). Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012;18:81-90
  • Harms MB, Ori-McKenney KM, Scoto M, Tuck ep, Ebell S. Ma D, Masi S, Allred P, Al-Lozi M, Reilly MM, Miller LG, Jani-Ascadi A, Pestronk A, Shy ME, Muntoni F, Valee RB, Baloh RH. Mutations in the tail domain of DYNC1H1 cause dominant spinal muscular atrophy. Neurology. 2012;78:1714-20
  • Blackstone K (CHARTER Group). Diagnosing symptomatic HIV associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012;18:79-88
  • Ellis etal (CHARTER group). CD4 nadir is a predictor of HIV neurocognitive imapirement in the era of combination antiretroviral therapy. AIDS. 2011;25:1747-51
  • Zaidman CM, Malkus EC, Siener C, Florence J, Pestronk A, Al-Lozi M. Qualitative and quantitative skeletal muscle ultrasound in late-onset acid maltase deficiency. Muscle Nerve. 2011;44:418-23

Medical Training

Originally from Amman, Jordan, Dr. Al-Lozi received his medical degree from King Edward Medical College in Lahore, Pakistan. He went on to complete a residency in neurology at Johns Hopkins University and a fellowship in Neuromuscular Diseases at Washington University in Saint Louis.